Grant Esposito is a first-chair trial lawyer with decades of experience in complex commercial litigation for multinational companies in their most challenging and high-profile matters. He is also a trusted advisor to clients in a variety of key areas including antitrust, environmental, mass torts, product liability, regulatory and transactional disputes.
Throughout his career, Grant has secured notable victories in jury and bench trials throughout the U.S., as well as in arbitration proceedings. He has also been recognized as a leading lawyer by numerous legal and industry publications, including Chambers USA, New York Law Journal and Law 360.
Education
- Fordham University School of Law, J.D.
- Cornell University, B.A.
Admissions & Qualifications
- New York
Awards & Recognition
Best Lawyers in America 2012-2025
Chambers USA: New York, Litigation: General Commercial
Law360 MVP: Intellectual Property 2015
The Legal 500 United States, Dispute Resolution: Product Liability, Mass Tort and Class Action - Defense: Consumer Product 2023
The Legal 500 Unites States, Dispute Resolution: Financial Services Litigation
The Legal 500 United States: Healthcare: Life Sciences 2024
The Legal 500 United States: Media, Technology & Telecoms: Marketing & Advertising: 2024
National Law Journal, Litigation Trailblazers 2016
Matters
Representative Matters
In re Generic Pharmaceuticals Pricing Antitrust Litigation. Trial counsel in dozens of cases consolidated in an MDL proceeding, including proposed class actions, as well as actions by State AGs and individual purchasers alleging price fixing and market allocation.
Bethpage Toxic Tort Litigation. Trial counsel in class action and individual cases alleging environmental contamination and toxic torts in excess of $1 billion. Advise client on related regulatory issues.
Venture v. Vonage. Trial counsel in breach of contract dispute, defeated claim seeking in excess of $300 million.
Town of Oyster Bay v. Northrop Grumman. Trial counsel in environmental dispute arising from WWII-related contamination.
Mosher v. DaVita Healthcare Partners. Trial counsel for client in escrow dispute and related matters arising from $4.2 billion acquisition. Settled on favorable terms.
Amgen Inc., et al. v. Sandoz Inc., et al. Designed statutory construction strategy that defined the “patent dance” contained in the Biologics Price Competition and Innovation Act, which was affirmed by the U.S. Supreme Court.
In re OxyContin Litigation. Trial counsel for Sandoz; prevailed on all patents.
In re Fletcher International Ltd. Trial counsel for auditor. Secured dismissals in New York, Boston, and Louisiana for auditor in alleged Ponzi scheme seeking hundreds of millions in damages